A lupinoside prevented fatty acid induced inhibition of insulin sensitivity in 3T3 L1 adipocytes

Molecular and Cellular Biochemistry

Volumn 300, Issue 1-2, 2007, Pages 149-157

  Dey, Debleena ^a   Pal, Bikash C ^a   Biswas, Tanushree ^a   Roy, Sib Sankar ^a   Bandyopadhyay, Arun ^a   Mandal, Swapan Kumar ^a   Giri, Bir Bhanu ^b   Bhattacharya, Samir ^c  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Purulia Sainik School   (India)

^c VISVA BHARATI UNIVERSITY   (India)

Author keywords

Diabetes type 2; Free fatty acids; Glut 4 translocation; Insulin resistance; Insulin signal; Lupinoside

Indexed keywords

DEOXYGLUCOSE; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR KINASE; LUPINOSIDE; PALMITIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG PURIFICATION; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HORMONE INHIBITION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; DEOXYGLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GREEN FLUORESCENT PROTEINS; INSULIN; INSULIN RESISTANCE; MALE; MICE; PALMITATES; PHYTOTHERAPY; PLANT EXTRACTS; PUERARIA; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; SAPONINS; SIGNAL TRANSDUCTION;

CANIS FAMILIARIS; PUERARIA TUBEROSA; RATTUS;

EID: 34250014758     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9378-1     Document Type: Article

References (32)

1. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806
2. Reaven GM., Hollenbeck C, Jeng CY, Wu MS, Chen YD (1998) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24h in patients with NIDDM. Diabetes 37:1020-1024
3. Kelley DE, Mokan M, Simoneau JA, Mandarino LJ (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle, J Clin Invest 92:91-98
4. Boden G, Chen X, Ruiz J, White JV, Rossetti L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446
5. Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176
6. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-988
7. Boden G (1997) A role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10
8. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest.103:253-259
9. Itani SI, Ruderman NB, Frank S, Boden G (2002) Lipid induced insulin resistance in human muscle is associated with changes in diacylglycerol, Protein kinase C, and Ikb-α. Diabetes 51:2005-2011
10. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin-signalling cascade, Diabetes 48:1270-1274
11. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 27:50230-50236
12. 4)3 Is defective in muscle in type 2 diabetes and impaired glucose tolerance: Amelioration by rosiglitazone and exercise. Diabetes 52(8):1926-1934
13. Chavez JA, Knotts TA, Wang LiG Li-Ping, Dobrowsky RT, Florant GL, Summers SA (2003) Role of ceramide but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278:10297-10303
14. Reynoso R, Salgado LM, Calderon V (2003) High levels of palmitic acid lead to insulin resistance due to changes in the level of phosphorylation of the insulin receptor and insulin receptor substrate-1. Mol Cell Biochem 246:155-162
15. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270:12953-12956
16. Martin G, Schoonjans K, Lefebvre AM, Staels B., Auwerx J (1997) Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPAR α and PPAR γ activators. J Biol Chem 272:28210-28217
17. Stumvoll M, Haring HU (2002) Glitazones clinical effects and molecular mechanisms. Ann Med 34:217
18. Guan HP, Li Y, Jensen MV, Newgard CB, Steppan CM, Lazar MA (2002) A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nature Med 8:1122-1128
19. Storz P, Doppler H, Wernig A, Pfizenmaier K, Muller G (1999) Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells. Eur J Biochem 266:17-25
20. Kinjo J, Kishida F, Watanable K, Hashimoto F, Nohara T (1994) Five new triterpene glycosides from Russell lupine. Chem Pharm Bull 42:1874-1878
21. Tremblay F, Lavigne C, Jacques H, Marette A (2001) Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes 50:1901-1910
22. Roy SS, Mukherjee M, Bhattacharya S, Mandal CN, Ravi Kumar L, Dasgupta S, Bandyopadhyay I, Wakabayashi K (2003) A new cell secreting insulin. Endocrinology 144:1585-1593
23. Lowry OH, Rosenbrough NJ, Farr AE, Randall RJ (1951) Protein measurement with Folin Phenol reagent. J Biol Chem 193:265-275
24. Arner P (2005) Insulin resistance in type 2 diabetes - role of the adipokines. Curr Mol Med 5(3):333-339
25. Kitagawa I, Wang HK, Taniyama T, Yoshikawa M (1988) Saponin and sapogenol. XLI. Reivestigation of the structures of soyasapogenols A, B and E, Oleanene-sapogenols from soyabean.structures of soyasaponins I, II and III. Chem Pharm Bull 36:153
26. Arao T, Kinjo J, Nohara T, Isobe R (1997) Oleanene-type triterpene glycosides from puerariae radix. IV. Six new saponins from Pueraria lobata. Chem Pharm Bull 45:362-366
27. Pessin JE, Thurmond DC, Elmendorf JS, Coker KJ, Okada S (1999) Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. J Biol Chem 274:2593-2596
28. Kandror V (1999) Akt-2 binds to Glut4-containing vesicles and phosphorylates their component proteins in response to insulin. J Biol Chem 274:1458-1464
29. Gorski J, Nawrocki A, Murthy M (1998) Characterization of free and glyceride-esterified long chain fatty acids in different skeletal muscle types of the rat, Mol. Cell Biochem 178:113-118
30. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H (1994) The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43:1353-1357
31. Ho RC, Davy KP, Hickey MS, Summers SA, Melby CL (2002) Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans. Am J Physiol Endocrinol Metab 283:799-808
32. Turcotte LP, Swenberger JR, Zavitz Tucker M, Yee AJ (2001) increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese zucker rats. Diabetes 50:1389-1396